Apollomics

IPO

Apollomics, Inc. - Committed to the discovery and development of oncology combination therapies

Public · Foster City, United States · Founded 2015 · $7.8M raised

Employees
51–200
Founded
2015
Business Model
B2B
Total Funding
$7.8M
Last Round
$2.0M BridgeApr 2026
Rounds
2
Type
Public

About

Clinical-stage oncology biotech developing combination therapies for difficult-to-treat cancers including lung, brain, and other solid tumors.

Summary

Apollomics is a Biotech company based in Foster City, United States, founded in 2015. It has raised $7.8M in total across 2 rounds, most recently a $2.0M Bridge round in Apr 2026.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

BridgeApr 2026
$2.0M

Sign up to see all 3 rounds

SPAC Merger through Bridge — per-round amounts, valuations, and who invested in each round.

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Apollomics on Indexed.vc
<a href="https://indexed.vc/companies/apollomics"><img src="https://indexed.vc/api/badge/company/apollomics" alt="Apollomics on Indexed.vc" width="260" height="76" /></a>